A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2011
11/03/2011	US20110269676 Bifunctional molecules for inactivating hiv and blocking hiv entry
11/03/2011	US20110269675 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
11/03/2011	US20110269674 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
11/03/2011	US20110269673 Antimicrobial Peptides
11/03/2011	US20110269671 Nisin derivatives and the use thereof
11/03/2011	US20110269670 Carbohydrate binding molecules
11/03/2011	US20110268970 Mesoporous nanoparticles
11/03/2011	US20110268829 Quality of life for hepatitis c patients with a formulation for administration to the oral mucosa including lactobacillus delbrueckii subsp. bulgaricus and n-acetyl d-glucosamine
11/03/2011	US20110268825 Compositions that include anthocyanidins and methods of use
11/03/2011	US20110268808 Dual-release pharmaceutical suspension
11/03/2011	US20110268784 Clay-based hemostatic agents and devices for the delivery thereof
11/03/2011	US20110268775 Nanoparticle pharmaceutical formulations
11/03/2011	US20110268771 Chewable gelled emulsions
11/03/2011	US20110268763 Polynucleotides that stimulate neutrophils
11/03/2011	US20110268762 Immunization of avians by mucosal administration of non-replicating vectored vaccines
11/03/2011	US20110268761 Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition
11/03/2011	US20110268760 Salmonella vectored vaccines against chlamydia and methods of use
11/03/2011	US20110268758 Tuberculosis antigen detection assays and vaccines
11/03/2011	US20110268757 Use of phenol-soluble modulins for vaccine development
11/03/2011	US20110268750 Chimeric polynucleotides and polypeptides enabling secretion of a polypeptide of interest in association with exosomes and use thereof for the production of immunogenic compositions
11/03/2011	US20110268746 Human cytomegalovirus neutralizing antibodies and use thereof
11/03/2011	US20110268744 Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor
11/03/2011	US20110268740 Fully human influenza m2 specific antibodies
11/03/2011	US20110268739 Human binding molecules having killing activity against enterococci and uses thereof
11/03/2011	US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/03/2011	US20110268720 Formulations of 5-fluorocytosine and uses thereof
11/03/2011	US20110268709 Generation of Histocompatible Tissues Using Nuclear Transplantation
11/03/2011	US20110268703 Probiotic strain and antimicrobial peptide derived therefrom
11/03/2011	US20110268700 Dosage regimens for hcv combination therapy
11/03/2011	US20110268697 Hepatitis C Virus Inhibitors
11/03/2011	US20110268695 Use of hmgb fragments as anti-inflammatory agents
11/03/2011	US20110268694 Methods for treating vascular leak syndrome
11/03/2011	US20110268678 Vitamin d forming sunscreen
11/03/2011	US20110268677 Silicone Paste Compositions
11/03/2011	US20110268670 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
11/03/2011	US20110268669 Composition and method for treating eustachian tube dysfunction
11/03/2011	US20110268666 Novel gastroretentive delivery system
11/03/2011	US20110268665 Oil-based foamable carriers and formulations
11/03/2011	US20110268659 High shear application in drug delivery
11/03/2011	US20110268654 Compositions and methods for delivering a substance to a biological target
11/03/2011	CA2800891A1 Use of kukoamine a and kukoamine b
11/03/2011	CA2795559A1 Crystalline peptide epoxyketone immunoproteasome inhibitor
11/02/2011	EP2383573A1 Screening method for substance useful as agent for treating prostate cancer
11/02/2011	EP2383343A2 Recombinant varicella-zoster virus
11/02/2011	EP2383342A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
11/02/2011	EP2383295A1 IP-10 antibodies and their uses
11/02/2011	EP2382993A1 Combination of drugs with protein-binding prodrugs
11/02/2011	EP2382987A1 Storage of influenza vaccines without refrigeration
11/02/2011	EP2382986A2 Vaccine against streptococcus pneumoniae
11/02/2011	EP2382985A1 Recombinant avian-infectious coryza vaccine and method for producing same
11/02/2011	EP2382974A1 Use of cyclosquaramide compounds as anti-tumour agents
11/02/2011	EP2382200A1 Competitive inhibitors of type ii dehydroquinase enzyme
11/02/2011	EP2382193A1 Ppar agonist compositions and methods of use
11/02/2011	EP2381959A1 Stable vaccine compositions and methods of use
11/02/2011	EP2381944A1 Anti-viral compounds, treatment, and assay
11/02/2011	EP2381924A1 Method for adding sensory conditioning cues in a pharmacotherapeutic regimen
11/02/2011	EP2381786A1 Polymorphs of darunavir
11/02/2011	EP2351581A9 A vaccine composition against foot-and-mouth disease and the preparation method thereof
11/02/2011	EP2278977B1 Aromatic heterocyclic fused indolobenzadiazepine hcv ns5b inhibitors
11/02/2011	EP2051730B1 Anti-h5n1 influenza activity of the antiviral protein cyanovirin
11/02/2011	EP1836225B1 Kir-binding agents and methods of use thereof
11/02/2011	EP1732901B1 Antiviral 4-aminocarbonylamino-substituted imidazole compound
11/02/2011	EP1730110B9 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
11/02/2011	EP1684868B1 Treatment of hiv infections with hypochlorous acid-oxidised human blood plasma
11/02/2011	EP1425389B1 Human antibodies specific for interleukin 15 (il-15)
11/02/2011	EP1399416B1 Peptide deformylase inhibitors
11/02/2011	CN1989947B Process for the manufacture of particles containing antibotics and their application
11/02/2011	CN1883610B Chinese animal medicine for treating birds viral disease and method for preparing same
11/02/2011	CN1845745B Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus
11/02/2011	CN1814048B Chinese medicine liquid capsule of Folium callicarpae Nudiflorae, preparing method and quality control method
11/02/2011	CN1629185B Fusion proteins of mycobacterium tuberculosis antigens and their uses
11/02/2011	CN1572298B Arbidol containing compound preparation
11/02/2011	CN102232083A 禽流感疫苗 Bird flu vaccine
11/02/2011	CN102232078A 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
11/02/2011	CN102229939A Optimized high-activity human lysozyme gene as well as expression vectors and applications thereof
11/02/2011	CN102229934A Efficient production method and application of antimicrobial peptide PR-39 of pig small intestine in pichia pastoris
11/02/2011	CN102229933A Aptamer capable of identifying hepatitis C virus (HCV) nonstructural 5A (NS5A) protein, derivatives thereof and screening method and use thereof
11/02/2011	CN102229932A Nucleic acid aptamer capable of identifying HCV E1E2 (hepatitis C virus E1E2), nucleic acid aptamer derivatives and screening method and application thereof
11/02/2011	CN102229921A Preparation method of trichoderma longibrachiatum lyase for treating fungal diseases
11/02/2011	CN102229916A Chicken Flavivirus and inactivated vaccine thereof
11/02/2011	CN102229915A EV71 virus monoclonal antibody, hybridoma cell line and application
11/02/2011	CN102229667A Polyethylene glycol modified porcine alpha-interferon, preparation method and application thereof
11/02/2011	CN102229666A Preparation method and application of animal-derived cationic antimicrobial peptides
11/02/2011	CN102229664A Recombinant melittin and application thereof
11/02/2011	CN102229660A Truncated human papillomavirus 33 type L1 protein
11/02/2011	CN102229659A Rana nigromaculata antibacterial peptide and gene and application thereof
11/02/2011	CN102229650A High purity lipopeptides, lipopeptide micelles and processes for preparing same
11/02/2011	CN102229634A Levo-isovaleryl spiramycin I and preparation, preparation method and application thereof
11/02/2011	CN102229605A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/02/2011	CN102229588A Briarane type diterpenoid compounds with anti-tumor and antibacterial activities and application thereof
11/02/2011	CN102229580A Novel pleuromutilin derivate, preparation method and medical use thereof
11/02/2011	CN102229572A 3-fluorophenyl-quinazoline-4 (3H)-ketone compound and preparation method thereof
11/02/2011	CN102229547A Naphthyl phenyl ether benzenesulfonamide derivative and preparation method and purpose thereof
11/02/2011	CN102229526A Method for separating, extracting and purifying isomagnolol in plant, namely Streblus asper
11/02/2011	CN102228688A OmpC-HBsAg (Outer membrane protein Complex-Hepatitis B surface Antigen) 'a' chimeric epitope therapeutic vaccine for hepatitis B
11/02/2011	CN102228687A Freeze-dried live attenuated hepatitis A vaccine not containing gelatin or human albumin protective agent and preparation method for freeze-dried live attenuated hepatitis A vaccine
11/02/2011	CN102228686A Process for preparing veterinary rabies inactivated and freeze-dried vaccine through suspension culture cell
11/02/2011	CN102228685A Preparation method of iridovirus cell inactivated vaccine for Chinese giant salamanders, and application method thereof
11/02/2011	CN102228679A Chicken interferon gamma combined medicament and application
11/02/2011	CN102228675A Enema for treating dysentery

1 ... 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 ... 1798